Welcome to our dedicated news page for Stepan Co. (Ticker: SCL), a resource for investors and traders seeking the latest updates and insights on Stepan Co..
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Stepan Co.'s stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Stepan Co.'s position in the market.
Stepan Company reported first-quarter 2024 results with net income at $13.9 million and adjusted net income at $14.7 million, down 11% year-over-year. EBITDA was $50.2 million, and adjusted EBITDA was $51.2 million, up 5% year-over-year. Global sales volume increased by 1%. The company is on track to achieve its $50 million cost reduction goal for 2024, recognizing $18 million in pre-tax savings in the first quarter.
Stepan Company (NYSE: SCL) declared a quarterly cash dividend of $0.375 per share, payable on June 14, 2024, to stockholders of record on May 31, 2024. This marks the 56th consecutive year of dividend increases. Stepan is a major manufacturer of chemicals used in various industries, including surfactants, polyurethane polyols, and CASE industries.
